On September 8, 2020 Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, reported that management will present an overview of the company’s business strategy and development-stage programs at two upcoming virtual investor conferences (Press release, Spectrum Pharmaceuticals, SEP 8, 2020, View Source [SID1234564715]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Rodman & Renshaw 22nd Annual Global Investment Conference, Sponsored by H.C. Wainwright, Monday, September 14, 2020 at 2:00 p.m. ET.
Cantor Virtual Global Healthcare Conference, Thursday, September 17, 2020 at 10:40 a.m. ET.
A live webcast of the presentations will be available from the Investor Relations section of the company’s website at View Source with a replay available shortly after each event.